Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06328127 · ClinicalTrials.gov registry record · NA
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
A NA study of Hematopoietic Stem Cell Transplant, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 3
- Study locations
NCT06328127: Recruiting NA study of Hematopoietic Stem Cell Transplant, sponsored by Brigham and Women's Hospital.
NCT06328127 is a NA study of Hematopoietic Stem Cell Transplant that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants, above the 54-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (641% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06328127, a NA study of Hematopoietic Stem Cell Transplant, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Primary Outcome
Compare anxiety symptoms between the two groups at 10 weeks using the 7-item Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A). The HADS-A subscale ranges from 0-21, with higher scores indicating worse anxiety symptoms.
Conditions Studied
Interventions
- BEHAVIORAL PATH
Study Locations (3)
Florida
- Moffitt Cancer Center - Tampa
Massachusetts
- Dana Farber Cancer Institute - Boston
North Carolina
- Duke Cancer Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2030-05-31 |
| Phase | NA |
What NCT06328127 shows while recruiting
NCT06328127 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 54-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (641% higher).
The record links to 1 condition, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which PATH is the first listed.
NCT06328127 reports a single indexed study location in Florida, Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06328127 about?
NCT06328127 is a clinical study titled "Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors". This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
What is the current status of trial NCT06328127?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-12-17. Estimated completion is 2030-05-31.
What conditions does trial NCT06328127 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant.
What interventions are being tested in trial NCT06328127?
The interventions under investigation include: PATH (BEHAVIORAL).
Who is sponsoring clinical trial NCT06328127?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06328127 being conducted?
This trial has 3 study locations across Florida, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06328127's enrollment target sits among peer trials
400 1st of 8 higher than 8 of 8 other Hematopoietic Stem Cell Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
RECRUITING · NA
-
Music Therapy and Hematopoietic Stem Cell Transplant
COMPLETED · NA
-
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
COMPLETED · NA
-
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RECRUITING · Phase 1
-
T Cell Therapy of Opportunistic Cytomegalovirus Infection
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI